Figures & data
Table 1 Results from urine samples (n=15) after ingestion of two tablets of a prescription drug containing 400 mg paracetamol +30 mg codeine phosphate by a healthy drug-naïve male volunteer
Table 2 Frequency and share of positive results for drugs-of-abuse in patient urine samples (n=2,272), as determined by screening with HPLC-MS/MS
Table 3 Results from CEDIA and HPLC-MS/MS in 25 urine samples with false-positive CEDIA buprenorphine
Figure 1 PPV and NPV with different cutoff concentrations of CEDIA for buprenorphine in patient urine samples (n=2,272).
![Figure 1 PPV and NPV with different cutoff concentrations of CEDIA for buprenorphine in patient urine samples (n=2,272).](/cms/asset/ff030f64-050b-49d9-92e3-253f0e676573/dsar_a_88935_f0001_c.jpg)
Table S1 Analytical performance of HPLC-MS/MS for relevant analytes